ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

PU

Peking University Cancer Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Peking University Cancer Hospital takes part in 25 sessions at ESMO 2026 in Madrid. Its program spans melanoma and gastrointestinal cancers, with attention to targeted and immune-based treatments. It examines whether MRI can identify colon cancer patients who may preserve their organs after immunotherapy.

OrganizationESMO 2026 Attendance
PU
Peking University Cancer Hospital
Beijing, China
Cancer centre & hospital
Cancer hospital and research institute of Peking University in Beijing, China.
Poster
Fri Oct 23
13:00–15:00
Al18F-HER2-BCH PET/CT guided precision neoadjuvant therapy for HER2-positive early breast cancer: FHERNAT trial
ePoster session 10
Breast cancerBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
A clinical study of ascites-derived autologous tumor-reactive T cells (GK02) for malignant ascites
Friday Poster Display session 6
Gastrointestinal cancers
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Efficacy and safety of TSN1611 plus cetuximab in patients with KRAS G12D mutant advanced solid tumors
Friday Poster Display session 6
Gastrointestinal cancers
Poster
Fri Oct 23
15:15–16:00
Safety and efficacy of QLC5508 (MHB088C) in patients (pts) with solid tumors: Data from a phase 1/2 trial
Friday Poster Display session 6
Gastrointestinal cancers
Abstract
Fri Oct 23
17:10–17:20
Poster
Sat Oct 24
12:00–12:45
Poster
Sat Oct 24
12:00–12:45
Poster
Sat Oct 24
12:00–12:45
Poster
Sat Oct 24
12:00–12:45
Phase 1b/2 trial of BGB-A445 (OX40 agonist) with or without tislelizumab in urothelial carcinoma, renal cell carcinoma, and melanoma
Saturday Poster Display session 3
Melanoma & skin cancersGenitourinary cancers
Poster
Sat Oct 24
12:00–12:45
Transcriptomic and epigenomic profiling of TIL products identifies determinants of clinical benefit in autologous TIL therapy (LM103) for advanced melanoma
Saturday Poster Display session 4
Melanoma & skin cancersBiomarkers & precision oncology
Abstract
Sat Oct 24
15:47–15:57
Talk
Sat Oct 24
19:15–19:30
Presentation of a clinical case: Improving patient tolerability of first line therapeutic options
ESMO Colloquium supported by Jazz Pharmaceuticals - Optimising the management of patients with advanced HER2+ gastroesophageal adenocarcinoma: ‘Testing’ the way to efficacy and safety
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
Efficacy and safety of HLX43 in previously treated advanced gastric cancer: A randomized phase 2 study
Sunday Poster Display session 3
Gastrointestinal cancers
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Chair
Mon Oct 26
08:30–10:00
Advancing targeted and immunotherapeutic strategies in upper GI cancer
with National Cancer Center Hospital East
Gastrointestinal cancers
Talk
Mon Oct 26
09:15–09:30
Personalised vaccines and cell therapies
Advancing targeted and immunotherapeutic strategies in upper GI cancer
Gastrointestinal cancers
Poster
Mon Oct 26
12:00–12:45
Efficacy of systemic therapies across lines in EP-NEC: Meta-analysis with contextualization of opamtistomig (LBL-024)
Monday Poster Display session 3
Sarcoma, CNS, head & neck and rare cancers
Poster
Mon Oct 26
12:00–12:45
Irinotecan liposome plus vincristine and apatinib for relapsed/refractory adult rhabdomyosarcoma: An exploratory study
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancers
Poster
Mon Oct 26
12:00–12:45
Talk
Mon Oct 26
14:45–15:00
Highlights of evidence generated in China-only trials during ESMO 2025 and 2026: Take home lessons for the future
ESMO-CSCO: Navigating the development pathways of cancer therapeutics -From China to the world

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Peking University Cancer Hospital

Tell us what you sell and we’ll find the people at Peking University Cancer Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction